Skip to main content

Table 3 Univariate and Multivariate Analyses of Clinical Parameters on PFS

From: Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population

Factor

Univariate Analysis

Multivariate Analysis

HR (95% CI)

P Value

HR (95% CI)

P Value

Age, year (< 65 vs. ≥ 65)

1.217 (0.813, 1.821)

0.340

——

——

Gender (female vs. male)

1.077 (0.689, 1.683)

0.745

——

——

Smoking (never vs. smoker)

0.685 (0.463, 1.102)

0.058

——

——

Family History(yes vs no)

1.012 (0.584, 1.703)

0.966

——

——

Family History (yes vs no)

1.858 (1.251, 2.760)

0.002

2.719(1.786, 4.159)

 < 0.001

ECOG PS (< 2 vs ≥ 2)

1.323 (1.105,1.725)

0.038

1.509(1.160, 1.946)

0.002

Histology (NSCLC vs SCLC)

2.348 (1.139, 4.840)

0.021

2.713(1.035, 4.563)

0.040

Neoplasm staging(III vs IV)

1.738 (1.111, 2.720)

0.015

1.238(0.770, 1.992)

0.378

No. of treatment line (1 vs ≥ 2)

0.828 (0.453, 1.514)

0.539

——

——

Treatment regimen (combination vs. monotherapy)

1.181 (0.817,1.708)

0.377

——

——

OA treated (yes vs no)

4.141 (2.715, 6.317)

 < 0.001

4.994(3.217, 7.753)

 < 0.001